An Optimal Treatment for Avulsion Fractures of the Base of Fith Metatarsal Bone
Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · May 3, 2012
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
This is a randomised prospective control trial. Patients with these fractures will normally first come to the Emergency Department (ED), where they have a foot radiograph confirming a fracture, and initial treatment only. This treatment is arbitrary, depends on the assessing clinician preference and usually varies from supportive tight bandage or a supportive plaster cast with crutches. All of these patients are normally referred to an orthopaedic fracture clinic. It is an orthopaedic trauma clinician in the fracture clinic who determines and takes the responsibility for the definitive mana...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (older than 15 years of age) with an acute closed isolated type I avulsion fractures of the base of the fifth metatarsal bone, (within 7 days of the injury)
- Exclusion Criteria:
- • Diabetes, Inflammatory arthritis, previous same foot tarso-metatarsal fractures, previous same foot surgery, more than 7 days since the injury.
About Sheffield Teaching Hospitals Nhs Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, South Yorkshire, United Kingdom
Patients applied
Trial Officials
Pavel - Akimau, MBChB
Principal Investigator
Sheffield Teaching Hopsitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials